Project Grant R21EY036563

Award Date 9/1/24
Completion Date 8/31/26
Dollars Obligated $248K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Portland, OR 97239, USA
Similar Awards
The National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), awarded a $300,001 Project Grant to Kineolabs, Inc. in Billerica, MA. The objective of this 1-year grant, which runs from July 1, 2025 to June 30, 2026, is to develop a portable, low-cost line-scan swept-source optical coherence tomography (LS-SS-OCT) imaging system. This system is intended for early detection and monitoring of age-related macular degeneration (AMD), diabetic retinopathy, and other eye...
The National Eye Institute (NEI) awarded a $231,000 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Tennessee Health Science Center (UTHSC) to develop a generalizable deep learning platform for unifying the quantification and assessment of experimental autoimmune uveitis (EAU). The overarching goals of this 2-year project are to: 1) Generate high-quality, multi-modal datasets of fundus, optical coherence tomography, histological, and...
The National Eye Institute (NEI) awarded a $179,964 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of California, Irvine (UCI) with a project period from March 1, 2025 to July 10, 2029. The project aims to develop innovative deep learning-based retinal optical coherence tomography (OCT) biomarkers to improve the diagnosis and management of optic neuropathies, a group of eye diseases that primarily target the optic nerve and frequently result in...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) to New York University School of Medicine provides $673,747 to develop a visible-to-near-infrared spanning optical coherence tomography (OCT) system capable of imaging retinal structures at a resolution of up to 0.5 microns. The goal is to leverage this advanced OCT technology to study the spatiotemporal relationship of key biomarkers such as macular pigments and retinal pigment epithelium melanosomes, and...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research federal grant program (CFDA 93.867) will fund the development of a new wide-field visible-light optical coherence tomography (WF-VIS-OCT) device to evaluate the oxygen-induced retinopathy (OIR) model in rats. The $623,090 award, effective September 1, 2024, will support the Oregon Health & Science University in three main efforts: 1) developing the WF-VIS-OCT system with 5-mm transverse resolution over a...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $246,000 to The Regents of the University of California, San Francisco (UCSF) to leverage programmable phage display peptidomes and high-throughput sequencing to identify autoantigens and antibodies important for uveitis, an ocular inflammatory disease. The two-year project aims to use comprehensive human and viral peptidome phage libraries to bio-pan for autoantigens...
The National Eye Institute (NEI) awarded a $417,162 Project Grant under the Vision Research program (CFDA 93.867) to the University of Houston System to develop and apply a polarization-sensitive swept source optical coherence tomography (PS-SSOCT) system for 3D mapping of the birefringent properties of the posterior eye in a non-human primate model. The goal is to quantify changes in birefringence within the retina, optic nerve head, and lamina cribrosa in response to changes in intraocular...
The National Eye Institute (NEI) awarded a $974,348 Project Grant under the Vision Research program (CFDA 93.867) to Wayne State University to conduct research on metabolic signatures in the vitreous of patients with bacterial and fungal endophthalmitis. The research aims to identify potential biomarkers for diagnosing endophthalmitis and guiding appropriate antimicrobial therapy. Specifically, the project will perform untargeted metabolomics analysis on vitreous samples from culture-positive...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), aims to develop a rapid, culture-independent diagnostic approach for detecting pathogens and antimicrobial resistance in sight-threatening ocular infections. The $425,000 award, effective August 1, 2024 through July 31, 2029, will support the Massachusetts Eye and Ear Infirmary in creating a metagenomic sequencing-based platform that uses portable nanopore sequencers to provide...
The National Eye Institute (NEI) awarded a $193,168 Project Grant (CFDA 93.867 Vision Research) to Duke University to develop a novel, auto-aligning hand-held optical coherence tomography (OCT) and OCT angiography (OCTA) probe for routine and repeatable high-quality retinal imaging in infants and children. The research aims to address the challenges associated with obtaining consistent OCT and OCTA data capture in uncooperative pediatric patients. The expected outcomes include a set of...

The National Eye Institute (NEI), through its Vision Research federal grant program (CFDA 93.867), awarded a $247,800 Project Grant to Oregon Health & Science University (OHSU) to develop novel tools to help diagnose and classify uveitis, a common cause of blindness in the United States. The project aims to (1) develop ultrahigh-resolution optical coherence tomography (OCT) for imaging the anterior and vitreous media of the eye, and (2) quantify and classify inflammation in the aqueous and vitreous humor of uveitis patients. The goal is to create OCT-based biomarkers to aid in the differential diagnosis of uveitis and assessment of disease severity, which can accelerate drug development and clinical trials for uveitis treatments. The project will run from Sep 1, 2024 to Aug 31, 2026.

Generated 7/1/25, 4:15 AM